|
⚲
|
| Keyboard |
| Martin Babler | |
|---|---|
| Firm | |
| Address | c/o Alumis Inc 280 East Grand Avenue South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Alumis Inc | 021-519656 | Executive Officer | 40.0 M of 40.0 M |
||
| Alumis Inc | 021-507205 | Executive Officer | 129.5 M of 259.0 M |
||
| Principia Biopharma Inc | 021-320699 | Executive Officer | 50.0 M of 50.0 M |
||
| Principia Biopharma Inc | 021-245075 | Executive Officer | 15.3 M of 15.3 M |
||
| Infinity Pharmaceuticals Inc | 021-184502 | Director | 78.5 M of 78.5 M |
||